03/05/2026
Proud to see four studies ranked among the 25 most-read articles of 2025 in the Canadian Medical Association Journal. From substance use and environmental health to surgical access and reproductive care, ICES research is helping inform policy and strengthen health systems across Ontario.
Explore the key findings from each study below.
1. People who receive emergency or hospital care after using hallucinogens face a significantly higher risk of dying within five years—about 2.5 times higher than the general population. They are especially at increased risk of su***de, as well as accidental drug poisoning, breathing problems, and cancer.
Read the study: https://www.cmaj.ca/content/197/8/E204 =4f04d7e0-1d24-4475-b213-c577106b0200
2. Wildfire smoke was associated with a sharp rise in asthma-related emergency department visits. After the first major smoke episode in early June 2023, asthma-related emergency department visits increased by 23.6%, peaking at a one‑day lag and lasting up to 5 days. Children experienced a brief 40% increase, while adults saw a more sustained 48% increase lasting a week. Other respiratory and cardiovascular outcomes were not significantly affected. Despite severe smoke exposure, the study found no detectable effect on emergency department visits for other respiratory conditions, ischemic heart disease, or non‑cardiorespiratory causes.
Read the study: https://www.cmaj.ca/content/197/17/E465 =4f04d7e0-1d24-4475-b213-c577106b0200
3. Coordinated referral and team‑based care models could largely eliminate prolonged wait times for joint replacement surgery. The study found that coordinated models (single‑entry referral, team‑based care, or both) produced larger reductions in high‑outlier wait times—specifically the 90th percentile and the proportion of patients exceeding wait‑time targets, compared with the status quo. These improvements targeted the longest waits rather than shifting median wait times.
Read the study: https://www.cmaj.ca/content/197/19/E524 =4f04d7e0-1d24-4475-b213-c577106b0200
4. Access to abortion medication improved dramatically across Ontario from 2017 to 2022. In 2017, almost no pharmacies (only 2%) dispensed mifepristone, but by 2022 this grew to 20%. As a result, most regions in the province—77% by 2022, up from 19%—had a local pharmacy where people could get abortion medication. Many more people gained local access to abortion services. In 2017, only 37% of women of reproductive age lived in an area with either a medication‑dispensing pharmacy or an abortion provider. By 2022, this increased to 91%, making access much more local and convenient.
Read the study: https://www.cmaj.ca/content/197/13/E345 =4f04d7e0-1d24-4475-b213-c577106b0200